Iron Uptake from Ferric Maltol in Patients with Iron Deficiency with or without Anemia: Post Hoc analysis of a Multicenter, Open-Label, Randomized, Phase 1 Clinical Study

被引：0
|
作者：
Howaldt, Stefanie [1 ]
Cody, Michael [2 ]
Mitchell, Jacqueline A. [3 ]
机构：
[1] HaFCED e K, Hamburg, Germany
[2] Shield Therapeut, Dallas, TX USA
[3] Shield Therapeut, Newcastle Upon Tyne, Tyne & Wear, England
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-185768
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Iron chelation of hetrombopag in aplastic anemia: a post hoc analysis of a phase II study
    Wenrui Yang
    Xin Zhao
    Guangsheng He
    Hong Chang
    Bing Han
    Sujun Gao
    Shunqing Wang
    Tong Chen
    Fei Li
    Yi Wang
    Xiaoyan Ge
    Rong Fu
    Zheng Ge
    Yingmei Li
    Hong Liu
    Xinjian Liu
    Miao Miao
    Liansheng Zhang
    Fengkui Zhang
    Annals of Hematology, 2022, 101 : 2611 - 2616
  • [42] A multicenter, randomized, open-label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis
    Yin, Jian
    Zhao, Mingming
    Xu, Xianhao
    Zhang, Meini
    Xu, Zucai
    Li, Zunbo
    Qin, Xinyue
    Li, Zhuyi
    Zhao, Chongbo
    Zhou, Hongyu
    Ma, Ying
    Cao, Wenfeng
    Wang, Guoping
    Lin, Yongzhong
    Zhang, Jizhong
    Zhang, Xu
    Cai, Hongbin
    Qian, Weidong
    Wang, Yiqi
    Zhang, Xinghu
    Liu, Guangzhi
    Wang, Jiawei
    Qiu, Wei
    Min, Lianqiu
    Li, Jing
    Deng, Hui
    Chu, Lan
    Zhang, Yifan
    Fang, Jianmin
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (08)
  • [43] Safety and Efficacy Of Ferumoxytol For The Episodic Treatment Of Iron Deficiency Anemia In Patients With a History Of Unsatisfactory Oral Iron Therapy: Results Of a Phase III Open-Label, Six Month Extension Study
    Vadhan-Raj, Saroj
    Dahl, Naomi V.
    Lau, Gloria
    Bernard, Kristine
    Li, Zhu
    De, Pallabi
    Allen, Lee F.
    Strauss, William
    BLOOD, 2013, 122 (21)
  • [44] Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: A multicenter, open-label, randomized trial
    Auerbach, M
    Ballard, H
    Trout, JR
    McIlwain, M
    Ackerman, A
    Bahrain, H
    Balan, S
    Barker, L
    Rana, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) : 1301 - 1307
  • [45] Efficacy of Cenobamate by Concomitant Antiseizure Medications in Patients With Uncontrolled Focal Seizures: Post-hoc Analysis of a Phase 3, Multicenter, Open-Label Study
    Klein, Pavel
    Vossler, David G.
    Krauss, Gregory L.
    Sperling, Michael R.
    Kamin, Marc
    Rosenfeld, William E.
    NEUROLOGY, 2021, 96 (15)
  • [46] Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study
    Vadhan-Raj, Saroj
    Ford, David C.
    Dahl, Naomi V.
    Bernard, Kristine
    Li, Zhu
    Allen, Lee F.
    Strauss, William E.
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (02) : E3 - E5
  • [47] Efficacy of ziprasidone against hostility in schizophrenia: Post hoc analysis of randomized, open-label study data
    Citrome, Leslie
    Volavka, Jan
    Czobor, Pal
    Brook, Shlomo
    Loebel, Antony
    Mandel, Francine S.
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (04) : 638 - 642
  • [48] A Multicenter, Randomized, Open-Label Trial Evaluating Deferasirox Compared with Deferoxamine for the Removal of Cardiac Iron in Patients with β-Thalassemia Major and Iron Overload (CORDELIA)
    Pennell, Dudley J.
    Porter, John B.
    Piga, Antonio
    Lai, Yongrong
    El-Beshlawy, Amal
    Beloul, Khawla
    Elalfy, Mohsen
    Yesilipek, Akif
    Kilinc, Yurdanur
    Lawniczek, Tomasz
    Habr, Dany
    Weisskopf, Marianne
    Zhang, Yiyun
    Aydinok, Yesim
    BLOOD, 2012, 120 (21)
  • [49] Potential New Treatment Option for Iron Deficiency Anemia Patients with a History of Unsatisfactory Oral Iron Therapy-Results of a Phase III, Randomized, Open-Label, Active-Controlled Trial of Ferumoxytol.
    Hetzel, David
    Urboniene, Audrone
    Bernard, Kristine
    Strauss, William
    Cressman, Michael
    Li, Zhu
    Allen, Lee F.
    BLOOD, 2012, 120 (21)
  • [50] Intravenous ferric carboxymaltose vs. oral iron substitution in patients with metastatic colorectal cancer (mCRC) and iron deficiency anemia: A randomized multicenter treatment optimization study (A Study in Progress Report)
    zur Hausen, G.
    Roetzer, I.
    Reichart, A.
    Pauligk, C.
    Hunfeld, K. -P
    Quidde, J.
    Hofheinz, R. -D.
    Al-Batran, S. -E.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 74 - 74
12345